| # | Drug | Count |
|---|---|---|
| 0 | RISPERIDONE | 40 |
| 1 | LORAZEPAM | 39 |
| 2 | METHOTREXATE SODIUM | 31 |
| 3 | OLANZAPINE | 31 |
| 4 | CITALOPRAM | 29 |
| 5 | DIAZEPAM | 28 |
| 6 | CITALOPRAM HYDROBROMIDE | 26 |
| 7 | QUETIAPINE | 26 |
| 8 | METHOTREXATE | 25 |
| 9 | ACETAMINOPHEN | 24 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 104 |
| 1 | Atypical Antipsychotic [EPC] | 84 |
| 2 | Corticosteroid [EPC] | 52 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 52 |
| 4 | Opioid Agonist [EPC] | 34 |
| 5 | Anti-epileptic Agent [EPC] | 25 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 24 |
| 8 | Typical Antipsychotic [EPC] | 21 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 7 | 0.0009 |
| 1 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 2 | Typical Antipsychotic [EPC] | 21 | 0.0008 |
| 3 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 4 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 5 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 6 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 7 | Actinomycin [EPC] | 1 | 0.0005 |
| 8 | Parenteral Iron Replacement [EPC] | 6 | 0.0004 |
| 9 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |